Abstract
For patients with acute myeloid leukemia, DNA sequencing before stem cell transplant can predict the chances of relapse, research shows. Scientists found that NPM1 alterations and/or FLT3 internal tandem duplications that persist after treatment and prior to a stem cell transplant were better predictors of relapse than flow cytometry.
©2023 American Association for Cancer Research
2023
American Association for Cancer Research
You do not currently have access to this content.